Wockhardt re-opens Indian CB sector

Pharma company brings first convertible since elections.
September 19, 2004

Mid-cap pharmaceuticals company Wockhardt demonstrated the new pricing reality for Indian issuers on Friday (September 17) with a $100 million deal via JPMorgan.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media